Novo Nordisk Pharmatech showing cGMP grade quats at CPhI Barcelona
Press Release | Novo Nordisk Pharmatech A/S
SEPTEMBER 27, 2016
Koege , Denmark: – Novo Nordisk Pharmatech A/S, the leading worldwide supplier of high-quality ingredients for the biopharmaceutical, pharmaceutical and personal care industries, will be exhibiting its new cGMP high purity ‘quats’ line of quaternary ammonium compounds at CPhI Worldwide in Barcelona.
The Danish-based specialist will be exhibiting at stand 5B1 in Hall 4 at Fira de Barcelona, showcasing the company’s recently developed quats, manufactured in accordance with cGMP Guide ICH Q7 for Active Pharmaceutical Ingredients, the highest available standard.
“These are very high quality products indeed,” said Chantale Julien, Product Manager.
“Our Quats are focused on pharmaceutical products vaccine manufacture and healthcare products. Accordingly, we analyze according to relevant multicompendial pharmacopoeias such as Ph.Eur., USP/NF, JP and BP,” Ms. Julien explained.
An innovative synthesis process makes Novo Nordisk Pharmatech a leading supplier of Benzalkonium Chloride, Cetrimide and CTAB. High levels of purity make them particularly suited for pharmaceutical applications, such as vaccine production. They act either as preservatives or active ingredients in many ophthalmic, nasal, oral and topical drugs and in a variety of solutions, ointments and creams. Their purity and characteristics are also ideal for a range of personal care products.
High purity compounds
Novo Nordisk Pharmatech is also one of the world’s leading suppliers of recombinant insulin in cell culture media, powering biopharma blockbuster drugs worldwide.
“Biosimilar manufacturers need to keep a strong focus on the manufacturing process of originator drugs. Using Novo Nordisk Pharmatech compounds reduces the risk of deviations in the process,” said Mrs. Chantale Julien, Product Manager, who will be part of the Novo Nordisk stand team, on hand to answer technical questions; Hall 4 stand 5B1.
About Novo Nordisk Pharmatech A/S>/h3>
Novo Nordisk Pharmatech A/S was established in 1949 as FeF Chemicals and since 1986 has been an important part of the Novo Nordisk pharmaceutical group. On 1 September 2015 the company’s name was changed to Novo Nordisk Pharmatech A/S. It is the leading worldwide supplier of recombinant insulin for cell growth media and pharmaceutical grade quaternary ammonium compounds (Quats) for the pharmaceutical, biopharmaceutical and personal care industries.
The company markets its products worldwide, with customers in more than 180 countries.
All Novo Nordisk Pharmatech products are manufactured to cGMP standards. The company has distinguished itself for global regulatory compliance, consistent high quality, extensive regulatory documentation, continuous availability, security of its global supply chain and high levels of service and support
For Financial Year 2015, Novo Nordisk reported world sales totaling 107,927 million Danish kroner (DEK) with more than half of all sales recorded in North America.
About CPhI Worldwide 2016
CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitors opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators, as well as gain insights on latest industry trends.
Now in its 27th year, the 2016 fair is a three-day event opening October 4 at the Fira de Barcelona exhibition center. Last year’s event in Madrid attracted some 36,000 delegates and 2,500 exhibitor companies from more than 150 countries worldwide.
The CPhl Worldwide show is being held alongside three other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events.
The Pre-Connect Conference on October 3 brings together senior stakeholders from all segments of the industry for a series of market-led educational modules on latest trends and topics while the CPhI Pharma Awards, presented on the first evening of the conference, honor innovative companies and leaders.
The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live More information at: http://www.cphi.com/europe/a
Vanessa León, Marketing Manager, Novo Nordisk
Tel:+45 404 262 84
Click on Novo Nordisk Pharmatech showing cGMP grade quats at CPhI Barcelona for more information.
Click on Novo Nordisk Pharmatech A/S to contact the company directly.
Click on Quats to learn more about high purity quaternary ammonium compounds.